Tradestie Institutional Equity Comparison Engine · Market Close Nov 13, 2026

IRBT vs ABBNY: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IRBT Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 5–3 Matrix Metrics)

IRBT Overall Winner 6-Pillar Tally: IRBT 6 – 0 ABBNY Matrix Metrics: IRBT 5 – 3 ABBNY

As of Nov 13, 2026, iRobot Corporation (IRBT) is the stronger overall head-to-head candidate over ABBNY (ABBNY) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IRBT carries a Unified Composite Score of 47.0/100 (HOLD) at $0.46 (N/M Forward P/E, -12.1% operating margin), whereas ABBNY carries 55.7/100 (HOLD) at $83.75 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While ABBNY currently prints a higher short-term Unified Composite Score (55.7/100 HOLD vs. IRBT 47.0/100 HOLD), IRBT captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-12.1% vs. N/A operating margin) and revenue trajectory (-24.6% vs. N/A YoY).
  • Technical & Structure Timing Caution: IRBT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.1); meanwhile ABBNY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IRBT vs ABBNY
IRBT NASDAQ Head-to-Head Winner
iRobot Corporation
Household Appliances
$0.46
-31.94% 1D
Market Cap $21.2M
TTM Revenue $1.56B
Forward P/E N/M
Beta / 30D Vol 4.15β · 460% Vol
Unified Composite Score
47.0 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -19.1%), weak momentum, RSI 36
RSI-14: 36.1 · SMA20: $2.35 · SMA50: $2.86
ABBNY US Equity
ABBNY
Institutional Equity
$83.75
+0.01% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.81β · 41% Vol
Unified Composite Score
55.7 / 100 HOLD
Tech 83.0 Fund 56.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.8%), weak momentum, RSI 41
RSI-14: 41.1 · SMA20: $85.16 · SMA50: $91.91

6-Pillar Scorecard Institutional Category Breakdown (IRBT 6 – 0 ABBNY)

Columns: Metric · IRBT · ABBNY
1. Valuation Multiples IRBT
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio 2.72x N/M
EV / Revenue N/M N/M
2. Growth & Scale IRBT
Revenue Growth (YoY) -24.6% N/A
Earnings Growth (YoY) -37.0% N/A
TTM Revenue (USD) $1.56B N/A
Market Cap $21.2M N/A
3. Profitability & Quality IRBT
Gross Margin 35.2% N/A
Operating Margin -12.1% N/A
Net Profit Margin 1.9% N/A
Return on Equity (ROE) 4.0% N/A
4. Balance Sheet & Cash Flow IRBT
Cash Generation (TTM) $45M EBITDA N/A
Cash Flow Margin 2.9% EBITDA Mgn N/A
Net Cash / Leverage $26.54 Book/Sh · 4.0% ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning IRBT
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 165.7% (31st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat IRBT
OpEx & R&D Intensity 47.3% of Rev ($740M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Furnishings, Fixtures & Appliances Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IRBT (5) vs ABBNY (3)
Institutional Metric IRBT ABBNY Criterion Row Edge
Market Capitalization
Scale
$21.2M N/A Larger Scale IRBT
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-24.6% N/A Higher Growth IRBT
Operating Margin (TTM)
Profitability
-12.1% N/A Higher Margin IRBT
Net Profit Margin
Profitability
1.9% N/A Higher Margin IRBT
Return on Equity (ROE)
Capital Efficiency
4.0% N/A Higher ROE IRBT
52-Week Range Position
Momentum
0% ($0–$13) 38% ($67–$110) Stronger Trend ABBNY
Beta / 30D Volatility
Risk Regime
4.15β · 460% Vol 1.81β · 41% Vol Lower Realized Risk ABBNY
Unified Institutional Score
Composite Signal
47.0 / 100 (HOLD) 55.7 / 100 (HOLD) Higher Composite ABBNY
Trailing 12M Revenue (USD)
Operating Scale
$1.56B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
35.2% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.72x PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$45M EBITDA ($26.54 Book/Sh · 4.0% ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ABBNY +80.93 pp
IRBT: -72.24% · ABBNY: +8.69%
3M Horizon ABBNY +80.29 pp
IRBT: -78.19% · ABBNY: +2.1%
6M Horizon ABBNY +80.29 pp
IRBT: -78.19% · ABBNY: +2.1%
1Y Horizon ABBNY +80.29 pp
IRBT: -78.19% · ABBNY: +2.1%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IRBT vs ABBNY. Trailing 12-month operating profitability (IRBT -12.1% vs ABBNY N/A) and valuation multiples (IRBT N/M vs ABBNY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IRBT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.56B
Gross Margin35.2%
Op. Margin-12.1%
ROE / Fwd P/E4.0% · N/M
ABBNY ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IRBT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 165.7%
IV Percentile 31st %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IRBT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABBNY UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABBNY Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IRBT Moat Profile Cyclical / Execution-Driven Positioning
Furnishings, Fixtures & Appliances Operator
Competes within the Furnishings, Fixtures & Appliances value chain with $21.2M market capitalization and -12.1% operating margin.
OpEx & R&D Reinvestment 47.3% of Rev ($740M)
90D Engineering Disclosures 0 Published
ABBNY Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ IRBT vs ABBNY Key Questions & Quantitative Answers

As of Nov 13, 2026, iRobot Corporation (IRBT) is the stronger overall head-to-head candidate over ABBNY (ABBNY) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). IRBT carries a Unified Composite Score of 47.0/100 (HOLD) at $0.46 (N/M Forward P/E, -12.1% operating margin), whereas ABBNY carries 55.7/100 (HOLD) at $83.75 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ABBNY currently prints a higher short-term Unified Composite Score (55.7/100 HOLD vs. IRBT 47.0/100 HOLD), IRBT captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-12.1% vs. N/A operating margin) and revenue trajectory (-24.6% vs. N/A YoY). Technical & Structure Timing Caution: IRBT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.1); meanwhile ABBNY is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

IRBT leads the Growth & Scale pillar: IRBT posts -24.6% YoY revenue growth and -37.0% YoY earnings growth on $1.56B TTM revenue (35.2% gross margin, -12.1% operating margin), compared with ABBNY at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IRBT generates $1.56B in USD-normalized revenue versus N/A for ABBNY. In operating R&D and SG&A reinvestment, IRBT deploys 47.3% of Rev ($740M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABBNY.

IRBT screens cheaper on headline valuation multiples. IRBT trades at N/M Forward P/E, N/M Trailing P/E, 2.72x PEG, and N/M EV/Revenue (2.9% EBITDA margin), whereas ABBNY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IRBT (4.0% ROE) versus ABBNY (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, IRBT carries 165.7% implied volatility (31st %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.15β · 460% Vol realized risk). By comparison, ABBNY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.81β · 41% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 13, 2026. For educational research only; not investment advice.